Sastasundar Ventures Ltd

Health X Platform Ltd (formerly Sastasundar Ventures Limited) has issued a disclosure regarding its 37th Annual General Meeting (AGM) scheduled for September 28, 2026, to be held via Video Conferencing. The company is providing a web-link for members who have not registered their email addresses to access the complete Annual Report for FY 2025-26 and the Notice of AGM. Additionally, the filing serves as an intimation to holders of physical securities to furnish KYC and Nomination details to the RTA, MUFG Intime India Private Limited, as per SEBI regulations. This includes updating PAN, address, bank details, and specimen signatures, with implications for dividend payments if not updated by April 1, 2024.

Health X Platform Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, as per SEBI regulations. The report details the company's corporate identity, operations, employee data, and business activities, which are primarily wholesale trading of pharmaceutical and OTC products, accounting for 98.80% of turnover. The company operates on a consolidated basis and serves the national market. Key contact for BRSR queries is Mr. Banwari Lal Mittal, Chairman & Managing Director. The report is also available on the company's website.

Health X Platform Ltd has filed its Annual Report for the Financial Year 2025-26, as per SEBI regulations. The report includes statutory reports, consolidated and standalone financial statements, directors' report, and management discussion and analysis. Key financial highlights for FY 2025-26 show a standalone net loss of ₹95.12 Lakhs and a consolidated net loss of ₹144.73 Lakhs. The company also reported a consolidated total comprehensive income of ₹73.68 Lakhs for the period. The report is available on the company's website and will be sent electronically to members.

Health X Platform Ltd has announced its 37th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 3:00 PM IST. The meeting will be conducted via Video Conferencing (VC) or Other Audio Visual Means (OAVM). Key agenda items include the adoption of audited financial statements for the fiscal year ended March 31, 2026, the re-appointment of a director retiring by rotation, and the re-appointment of Mrs. Anjana Dikshit as an Independent Director for a second five-year term. Additionally, the company seeks approval for its overall borrowing limit under Section 180(1)(c) of the Companies Act, 2013. The notice is being sent electronically to members with registered email addresses and is also available on the company's website.

Health X Platform Limited (formerly Sastasundar Ventures Limited) has announced its 37th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 3:00 PM IST. The meeting will be conducted via Video Conferencing (VC) or Other Audio Visual Means (OAVM), in compliance with circulars from the Ministry of Corporate Affairs and SEBI. The notice of the AGM, along with the annual report for the financial year ended March 31, 2026, will be submitted in due course. The intimation is also available on the company's website.

Health X Platform Ltd announced that its Board of Directors, in a meeting held on August 7, 2026, approved the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026, along with the Limited Review Report from statutory auditors. The board also approved the re-appointment of Mrs. Anjana Dikshit as an Independent Director for a second five-year term, effective November 10, 2026, subject to shareholder approval. Mrs. Dikshit is an IT professional with extensive experience and is not related to any existing directors or promoters. The financial results were reviewed by the Audit Committee.

Health X Platform Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved and took on record the standalone and consolidated financial results, which were reviewed by the Audit Committee. The company also announced the re-appointment of Mrs. Anjana Dikshit as an Independent Director for a second term of five years, effective November 10, 2026, subject to shareholder approval. Mrs. Dikshit is an IT professional with extensive experience in global ERP implementations and currently serves on the boards of multiple public limited companies.

Health X Platform (formerly Sastasundar Ventures) posted consolidated revenue from operations of ₹446.85 Cr for Q1 FY27, up 49.7% YoY from ₹298.43 Cr and up 19.6% QoQ from ₹373.78 Cr in Q4 FY26. But consolidated PAT collapsed to just ₹1.99 Cr, down 92.5% from ₹26.59 Cr a year ago — even as it marks a turnaround from Q4 FY26's ₹12.97 Cr loss. Net profit margin fell to 0.43% from 8.21% YoY, and operating margin (segment result before finance cost/tax over total income) turned negative at -1.90% versus +2.03% a year ago, though it improved from -7.00% in Q4 FY26. No street previews were found for this micro-cap, so vs-street is unknown; management has issued no specific Q1 FY27 numeric guidance to grade this print against directly (only the medium/long-term targets below), so vs-guidance is also unknown for the quarter itself. The compression is a two-segment story. Healthcare Network — the dominant segment at ₹411.78 Cr revenue (92% of the group, up 47.8% YoY) — posted a segment loss of ₹14.87 Cr before finance costs and tax, wider than the ₹13.09 Cr loss a year ago though narrower than Q4 FY26's ₹23.14 Cr loss; this segment carries the SastaSundar App/Retailer Shakti growth push. Financial Services, the historically profitable segment, saw its result fall to ₹5.57 Cr from ₹19.50 Cr YoY as "net gain on fair value changes" on the investment book dropped to ₹6.33 Cr from ₹19.69 Cr — a mark-to-market swing rather than an operating deterioration. The group's PBT of ₹1.97 Cr was ultimately salvaged by ₹11.32 Cr of net unallocable income at the holding-company level. Management's FY26 concall guidance targeted ₹6,000 Cr revenue by FY30 (₹4,000 Cr from Retailer Shakti, ₹2,000 Cr from the SastaSundar App) and progressive EBITDA margin improvement toward 5% at scale, with Retailer Shakti FY27 revenue seen at ~₹1,700 Cr and a 1% EBITDA margin for the full year. One quarter in, Healthcare Network is still loss-making at the segment level — the QoQ narrowing of losses is directionally consistent with that plan, but the YoY widening cuts against it, so the FY27 margin path is unconfirmed. No management press-release commentary was available in this filing to corroborate framing. Separately, the Board's June 10, 2026 Composite Scheme of Arrangement (merging Microsec Resources, Innogrow Technologies and Sastasundar Healthbuddy with Health X) remains pending regulatory approval with no accounting impact yet, beyond ₹14.75 lakh of standalone-entity scheme costs. Post quarter-end, the company won a tax dispute with a ₹65.19 lakh demand set aside (August 3, 2026) — immaterial to Q1 numbers but a minor tailwind heading into FY27. The next checkpoints are whether Healthcare Network's segment loss keeps narrowing toward break-even, whether Retailer Shakti tracks its ~₹1,700 Cr FY27 revenue/1% EBITDA path, and how the pending Scheme of Arrangement reshapes the group's segment mix once effective.

Health X Platform Ltd has announced a favorable outcome in its ongoing tax litigation with the Commissioner of Service Tax, Kolkata. The company had appealed a demand of ₹65,19,360/- for alleged contravention of the Finance Act, 1994 and non-payment of service tax. After multiple hearings and document submissions, the final order pronounced on July 30, 2026, ruled that the impugned demand is not sustainable. Consequently, the appeal filed by the company has been allowed, the demand set aside, and no penalties are imposable. The company stated there is no material financial impact.

Health X Platform Ltd has announced that its Board of Directors will convene on August 7, 2026. The primary agenda item for this meeting is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026. Following this announcement, the trading window for the company's securities will remain closed for 48 hours after the declaration of these financial results to the stock exchanges.